European Archives - Page 97 of 1263 - European Medical Journal

Genetic Testing Improves Diagnosis in Childhood Liver Failure

Metabolic and genetic disorders emerged as the most frequent aetiological group, reflecting broader diagnostic capabilities compared to earlier studies.

Unlocking the Future of Paediatric Myotonia

Stay tuned for an interactive video on the Lupin Neurosciences Sponsored symposium from EPNS 2025 titled Unlocking the…

Medicaid Reimbursement Boosts Postpartum Depression Screening

The study aimed to understand whether financial incentives impacted screening, diagnosis, and treatment for maternal mental health conditions.

HPV Vaccination from Adolescents to Adults

In this podcast, Kenneth Alexander and Jorg Schelling, experts in the fields of infectious disease and family medicine, respectively…

A New Era in Myeloma: An Interview with Elena Zamagni

In the beginning, when I was very young, I was more interested in acute leukaemia and the suffering of young people. When I got to…

High Pacemaker Implantation Rates After Transcatheter Aortic Valve Implantation

Rates of permanent pacemaker implantation exceed 20% in patients with aortic regurgitation.

Urine Tumour DNA Could Guide Therapeutic Decisions in Bladder Cancer

Profiling urine tumour DNA at baseline and after 3 months of treatment could identify whether patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer might not benefit from systemic immunotherapy.

Chronic Inflammation Linked to Increased Affective Disorders

Chronic exposure to systemic inflammation may be associated to a greater risk of affective disorders.

Can Post-Treatment MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy?

Pathologic complete response was accurately predicted by post-treatment MRI in patients with early triple-negative breast cancer having undergone neoadjuvant chemoimmunotherapy.

Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.